News & Events about Certara Inc.
Shares of Certara, Inc. (NASDAQ:CERT Get Rating) have received an average recommendation of Moderate Buy from the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the ...
Certara improves software capabilities by expanding into deep learning and data fabricPRINCETON, N.J., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT),today announced it hasacquiredVyasaAnalytics, LLC. Vyasaprovides scalable deep-learning software whichallowslife sciences ...
Certara, Inc. (NASDAQ:CERT Get Rating) major shareholder Avatar Parent L.P. Eqt sold 29,954,521 shares of Certara stock in a transaction dated Thursday, December 8th. The shares were sold at an average price of $15.00, for a total value of $449,317,815.00. The sale was disclosed in a legal filing ...
Certara, Inc. (NASDAQ:CERT Get Rating) major shareholder Avatar Parent L.P. Eqt sold 29,954,521 shares of the firms stock in a transaction on Thursday, December 8th. The stock was sold at an average price of $15.00, for a total value of $449,317,815.00. The sale was disclosed in a ...
Globe Newswire
5 months ago
PRINCETON, N.J., Aug. 31, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the following investor conferences: Morgan Stanley 20th Annual Global Healthcare ConferenceDate and Time: Tuesday, September ...